Search results
Nestlé taps into weight loss drug market with new frozen food line for Ozempic users
Salon via Yahoo Finance· 9 hours agoGLP-1 agonists, a class of type 2 diabetes medication that gained popularity online as an anti-...
Eli Lilly to Spend $5.3 Billion to Make More Mounjaro, Zepbound
The Wall Street Journal· 24 hours agoThe outlay to expand an Indiana production site, combined with a previous $3.7 billion commitment,...
How digital health companies are capitalizing on the GLP-1 boom
CNBC· 12 hours agoNovo Nordisk's blockbuster weight loss drug, which contains the second generation GLP-1 active...
Axios Vitals
Axios· 3 days agoThe blockbuster success of new anti-obesity drugs helped boost the corporate reputations of pharmaceutical brands, according to new rankings from the annual Axios/Harris Poll 100. Why it matters ...
More Weight Loss With Anti-Obesity Meds and Hormone Therapy?
Medscape· 3 days ago"To date, there are no studies comparing weight loss outcomes to any of the anti-obesity...
Eli Lilly to invest $5.3 billion to expand production of Zepbound and Mounjaro By Investing.com
Investing.com· 1 day agoEli Lilly (NYSE:LLY) is making a $5.3 billion investment to expand manufacturing for its high-demand...
Nestlé introduced a new frozen food brand aimed at weight-loss drug users
Axios· 4 days agoNestlé on Tuesday announced a new frozen food brand aimed at weight-loss drug users in one of the...
Nestlé to debut Vital Pursuit healthy food brand for Ozempic, Wegovy medication users
USA TODAY via Yahoo News· 4 days agoNestlé is launching a new food line next year meant to support Americans who use weight-management...
Wegovy, Saxenda study reveals surprising trend for weight loss drugs
USA Today· 5 days agoMore than half of people prescribed weight-loss drugs Saxenda and Wegovy over the past decade ended...
AstraZeneca aims for $80 billion in total revenue by 2030 By Reuters
Investing.com· 5 days agoThe Anglo-Swedish drugmaker had reported total revenue of $45.81 billion last year and earlier...